A systematic, platform-agnostic search is needed to get new and improved COVID-19 vaccines that provide longer and broader immunity, US Food and Drug Administration’s Peter Marks urged in recent New England Journal of Medicine interview.
More work needs to be done to “keep ahead of the virus,” the Center for Biologics Evaluation and Research Director...







